Form 8-K - Current report:
SEC Accession No. 0001493152-26-018202
Filing Date
2026-04-21
Accepted
2026-04-21 08:00:41
Documents
13
Period of Report
2026-04-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41209
2 EX-99.1 ex99-1.htm EX-99.1 21999
3 GRAPHIC ex99-1_001.jpg GRAPHIC 19494
  Complete submission text file 0001493152-26-018202.txt   261400

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pulm-20260416.xsd EX-101.SCH 3017
5 XBRL LABEL FILE pulm-20260416_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE pulm-20260416_pre.xml EX-101.PRE 22360
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3213
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 26876769
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)